0.0180
0.0000
(0.00%)
At close: 4:10:50 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-6,520.9760
-6,520.9760
-8,083.1720
-8,653.3890
-4,549.2980
Investing Cash Flow
-1,059.0710
-1,059.0710
-690.8320
-3,117.9600
-213.0710
Financing Cash Flow
9,885.3250
9,885.3250
1,390.7950
482.2880
22,939.9400
End Cash Position
5,025.1160
5,025.1160
2,719.8380
10,103.0470
21,392.1080
Interest Paid Supplemental Data
43.0030
43.0030
--
56.6030
--
Capital Expenditure
-1,059.0710
-1,059.0710
-690.8320
-3,117.9600
-213.0710
Issuance of Capital Stock
10,515.0800
10,515.0800
1,847.3480
758.3170
24,195.9180
Repurchase of Capital Stock
--
--
--
--
-1,026.0510
Free Cash Flow
-7,580.0470
-7,580.0470
-8,774.0040
-11,771.3490
-4,762.3690
6/30/2021 - 4/6/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACR.AX Acrux Limited
0.0330
+3.12%
1AI.AX Algorae Pharmaceuticals Limited
0.0060
-14.29%
1AD.AX AdAlta Limited
0.0170
0.00%
ANR.AX Anatara Lifesciences Ltd
0.0510
+6.25%
AGN.AX Argenica Therapeutics Limited
0.6950
+6.11%
ACW.AX Actinogen Medical Limited
0.0270
0.00%
CMB.AX Cambium Bio Limited
0.3900
0.00%
ALA.AX Arovella Therapeutics Limited
0.1900
+2.70%
AVE.AX Avecho Biotechnology Limited
0.0040
+33.33%
BGT.AX Bio-Gene Technology Limited
0.0520
-1.89%